INTERCEPT PHARMACEUTICALS, INC. Business Finance Contracts & Agreements

69 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Second Supplemental Indenture to 3.50% Convertible Senior Secured Notes Due 2026 – Intercept Pharmaceuticals, Inc. and U.S. Bank Trust Company, N.A.
Indenture Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2023
Third Supplemental Indenture to Senior Debt Securities Indenture between Intercept Pharmaceuticals, Inc. and U.S. Bank Trust Company, N.A.
Indenture Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2023
Description of Intercept Pharmaceuticals, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2023
Exchange Agreement between Intercept Pharmaceuticals, Inc. and Investor for 3.50% Convertible Senior Secured Notes due 2026
Exchange Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2022
Intercept Pharmaceuticals, Inc. Performance Stock Unit Grant Agreement under Amended and Restated Equity Incentive Plan
Equity Distribution Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2022
Intercept Pharmaceuticals, Inc. Restricted Stock Unit Award Agreement for Directors under Amended and Restated Equity Incentive Plan
Equity Distribution Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2022
Intercept Pharmaceuticals, Inc. Restricted Stock Unit Grant Agreement under Amended and Restated Equity Incentive Plan
Equity Distribution Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2022
Intercept Pharmaceuticals, Inc. Director Stock Option Grant Agreement under Amended and Restated Equity Incentive Plan
Warrant Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2022
Intercept Pharmaceuticals, Inc. Amended and Restated Equity Incentive Plan Stock Option Grant Agreement
Equity Distribution Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2022
Deed of Amendment to Share Purchase Agreement between Intercept Pharmaceuticals, Inc. and Mercury Pharma Group Limited (July 1, 2022)
Modification Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2022
Deed of Amendment to Safety Data Exchange Agreement between Intercept Pharmaceuticals, Inc. and Mercury Pharma Group Limited (July 1, 2022)
Modification Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2022
Deed of Amendment to Transitional Services Agreement between Intercept Pharmaceuticals, Inc. and Advanz Pharma Services (UK) Limited (July 26, 2022)
Modification Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2022
Asset Purchase Agreement between Intercept Pharma Europe Ltd. and Advanz Pharma Services (UK) Limited (May 5, 2022)
Purchase Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2022
Share Purchase Agreement between Intercept Pharmaceuticals, Inc. and Mercury Pharma Group Limited (May 5, 2022)
Shareholders Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NJ
2022
Description of Intercept Pharmaceuticals, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2022
Security Agreement among Intercept Pharmaceuticals, Inc., Guarantors, and U.S. Bank National Association (Collateral Agent) dated August 17, 2021
Security Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2021
First Supplemental Indenture to Senior Debt Securities Indenture between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association (2021)
Indenture Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
DE
2021
Indenture Agreement between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association (August 17, 2021)
Indenture Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2021
Description of Intercept Pharmaceuticals, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2021
Intercept Pharmaceuticals, Inc. Restricted Stock Unit Award Agreement for Directors under 2012 Equity Incentive Plan
Equity Distribution Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Intercept Pharmaceuticals, Inc. Director Stock Option Agreement under 2012 Equity Incentive Plan
Warrant Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan Performance Stock Unit Grant Agreement
Equity Distribution Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan Restricted Stock Unit Grant Agreement
Equity Distribution Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan Stock Option Grant Agreement (Employee/Consultant)
Warrant Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Description of Intercept Pharmaceuticals, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2020
Second Supplemental Indenture to Senior Debt Securities Indenture between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association (2.00% Convertible Senior Notes due...
Indenture Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
DE
2019
Securities Purchase Agreement between Intercept Pharmaceuticals, Inc. and Purchasers (May 8, 2019)
Purchase Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Underwriting Agreement for 2.00% Convertible Senior Notes Due 2026 between Intercept Pharmaceuticals, Inc. and Underwriters
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Underwriting Agreement for 2,400,000 Shares of Common Stock between Intercept Pharmaceuticals, Inc. and Underwriters (Goldman Sachs, Credit Suisse, Jefferies)
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan Performance Stock Unit Grant Agreement
Equity Distribution Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan Restricted Stock Unit Grant Agreement
Equity Distribution Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan Stock Option Grant Agreement (Employee/Consultant)
Equity Distribution Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Intercept Pharmaceuticals, Inc. Performance Share Award Grant Notice and Agreement under 2012 Equity Incentive Plan
Equity Distribution Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2018
Intercept Pharmaceuticals, Inc. Performance Stock Unit Award Grant Notice and Agreement under 2012 Equity Incentive Plan
Equity Distribution Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2018
Securities Purchase Agreement between Intercept Pharmaceuticals, Inc. and Purchasers dated April 4, 2018
Purchase Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2018
Underwriting Agreement for Sale of Common Stock between Intercept Pharmaceuticals, Inc. and Credit Suisse Securities (USA) LLC and Jefferies LLC (April 5, 2018)
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2018
Call Option Confirmation Agreement between Royal Bank of Canada and Intercept Pharmaceuticals, Inc. (July 1, 2016)
Warrant Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2016
First Supplemental Indenture to Senior Debt Securities Indenture between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association (3.25% Convertible Senior Notes due...
Indenture Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
DE
2016
Indenture Agreement between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association (July 6, 2016)
Indenture Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2016
Underwriting Agreement for $400,000,000 3.25% Convertible Senior Notes due 2023 between Intercept Pharmaceuticals, Inc. and Underwriters (RBC Capital Markets, LLC and UBS...
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2016